VPM
SPRB

Vanguard Portfolio Management’s Spruce Biosciences SPRB Stock Holding History

Vanguard Portfolio Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$999K Buy
+18,496
New +$1.03M ﹤0.01% 2960

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Vanguard Portfolio Management's SPRB Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 18,496 shares worth $999K. The stake represents ﹤0.01% of the portfolio and ranks #2960 among its holdings.

35 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Vanguard Portfolio Management held 18,496 shares of Spruce Biosciences worth $999K as of Q2 2026.
  • Spruce Biosciences was a new Vanguard Portfolio Management position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2960 holding.
  • 35 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.